Open Access
Issue
BIO Web Conf.
Volume 240, 2026
The 2026 International Conference on Biomedicine, Neuroscience and Biostatistics (ICBNB 2026)
Article Number 01033
Number of page(s) 5
Section Biomedicine, Neuroscience and Biostatistics
DOI https://doi.org/10.1051/bioconf/202624001033
Published online 24 June 2026
  • F. Bray et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians 74, 229–263 (2024). [Google Scholar]
  • A. Zafar, S. Khatoon, M. J. Khan, J. Abu & A. Naeem. Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov Onc 16, 607 (2025). [Google Scholar]
  • H. A. Yousefi Rizi, D. H. Shin & S. Yousefi Rizi. Polymeric Nanoparticles in Cancer Chemotherapy: A Narrative Review. ijph https://doi.org/10.18502/ijph.v51i2.8677 (2022) . [Google Scholar]
  • X. Zhang et al. Membrane-derived biomimetic nanovesicles in anti-tumor immunotherapy: Advances and outlook. Acta Pharmaceutica Sinica B 16, 1388–1420 (2026). [Google Scholar]
  • Q. Guo, S. Wang, R. Xu, Y. Tang & X. Xia. Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform. RSC Adv. 14, 10608–10637 (2024). [Google Scholar]
  • V. Kumari et al. Emerging role of cell membrane-coated nanoparticles in targeted therapy for brain disorders. Biomaterials Advances 184, 214822 (2026). [Google Scholar]
  • Z. Zeng et al. Nanobiotechnology-driven advances in sonodynamic therapy: unlocking the potential of sonosensitizers in clinical translation. RSC Adv. 16, 6002–6025 (2026). [Google Scholar]
  • Z. Liao et al. Red Blood Cell Membrane-Camouflaged Nanoparticles for Synergistic Sonodynamic Therapy and TGF-β Inhibition to Reprogram Immunosuppressive Tumor Microenvironment. ACS Appl. Mater. Interfaces 17, 41680–41695 (2025). [Google Scholar]
  • Y. Pan et al. Engineered Red Blood Cell Membrane-Coating Salidroside/Indocyanine Green Nanovesicles for High-Efficiency Hypoxic Targeting Phototherapy of Triple-Negative Breast Cancer. Adv. Healthc. Mater. 11, 2200962 (2022). [Google Scholar]
  • R. R. Syed Altaf et al. Fusing Biomimetic Engineering with Nanotechnology: The Rise of Platelet Membrane-Coated Nanoparticles as a Versatile Platform for Biomedical Innovation. Adv. Therap. 8, (2025). [Google Scholar]
  • T. Li, D. Xiao, Y. Yin & L. Hu. Research Progress on Nano-Drug Delivery Systems for Photothermal Cancer Therapy. IJN Volume 21, 1–24 (2026). [Google Scholar]
  • L. Wu et al. Platelet membrane-coated nanoparticles for targeted drug delivery and local chemo-photothermal therapy of orthotopic hepatocellular carcinoma. J. Mat. Chem. B 8, 4648–4659 (2020). [Google Scholar]
  • Q. Zhang et al. Anti-inflammatory mechanisms of neutrophil membrane-coated nanoparticles without drug loading. J. Control. Release 369, 12–24 (2024). [Google Scholar]
  • P. Kesharwani et al. PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy. Mol Cancer 24, 205 (2025). [Google Scholar]
  • J. Zhou et al. Cancer cell membrane-camouflaged paclitaxel/PLGA nanoparticles for targeted therapy against lung cancer. Biomed. Pharmacother. 177, 117102 (2024). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.